CONX Corp. financial metrics

Period Q1 2026 · Filed 13 Apr 2026

Key metrics snapshot

Return On Equity

316%

Trailing 12 months · Through 30 Sep 2025

YoY relative change: +4318%

SEC metric history

Return On Assets

28%

Trailing 12 months · Through 30 Sep 2025

YoY relative change: -1978%

SEC metric history

Current Ratio

29.1x

Period-end balance · Through 30 Sep 2025

YoY relative change: -19%

SEC metric history

Profitability

Metric Latest value YoY relative change
Return On Equity 316%
Trailing 12 months · 30 Sep 2025
+4318%
Return On Assets 28%
Trailing 12 months · 30 Sep 2025
-1978%

Financial Health

Metric Latest value YoY relative change
Current Ratio 29.1x
Period-end balance · 30 Sep 2025
-19%
Quick Ratio 26.61x
Period-end balance · 30 Sep 2025

Share Metrics

Metric Latest value YoY relative change
Entity Common Stock, Shares Outstanding 18,928,585
Period-end balance · 08 Apr 2026
0%
Comparisons, sources and research notes
Sources and sharing

CONX Corp. Financial Facts

Context
Latest metrics period: Q1 2026
Latest reported value
Return On Equity 316%

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open metric pages to inspect the reported history.

Tracking and update notes

Why revisit this company facts page

Company facts change as new 10-Q and 10-K filings update the latest reported period, headline values, and cross-company comparison context.

Latest source-backed update
Latest metrics period Q1 2026
Why come back
Use the next filing cycle to compare new facts against this baseline and then verify the detailed metric history.
  • Current latest metrics period: Q1 2026.
  • Most recent SEC facts end date on this page: 08 Apr 2026.
  • Save this filer to return when the next filing-backed metric period changes the picture.

Freshness comes from the latest SEC company facts period available for this filer and the linked metric history pages.

Latest update

Latest update for CONX Corp.

New fact period available

Latest financial period: Q3 2025. Reopen this facts page to verify the newest reported period against the prior baseline.

Update date

13 Apr 2026

Page type

Company facts

Latest period

Q1 2026

SEC-backed company facts were refreshed from filings filed on 13 Apr 2026.

Benchmark Context

How Return On Equity compares

Return On Equity is up about 4318% versus the comparable prior period.

Compared with

Compared with CONX Corp.'s recent history first. Same-industry peer context appears only when enough SEC-backed benchmark coverage exists.

Why this is notable

Return On Equity already has a self-history signal here, but same-industry benchmark context waits until the benchmark sample is strong enough.

  • Latest comparable period on this page: Q1 2026.
  • Peer context will appear when enough companies report a comparable value for this metric.
  • Open the metric history first if you want to verify the exact period-to-period change.

Industry benchmark context uses SEC-reported values from the same methodology version. Latest periods may differ across companies.

Filing notes and source

Key facts

  • CONX Corp. financial facts use SEC filings; any third-party reference is labeled separately.
  • Latest metrics period on this page: Q1 2026.
  • Headline metric: Return On Equity 316%.

Change

  • Return On Equity YoY relative change: +4318%.
  • Most recent SEC facts end date: 08 Apr 2026.

Research use

  • This gives a beginner-friendly first read before you inspect detailed formulas and metric tables.
  • Metric cards link to SEC history; a third-party reference may use a different or unverified reporting period.

Evidence

Based on latest 10-Q/10-K

Based on company facts extracted from SEC 10-Q/10-K XBRL filings where available. Open company facts to inspect the reported metric history.

View source filing

Latest financial snapshot (2026-04-08) highlights Return On Equity 316.3%, Return On Assets 27.9%, and Current Ratio 29.1x.

Valuation Snapshot

SEC-only DCF estimate using a normalized free cash flow base, cash, debt, and reported share count when available.

No market comparison No market comparison Low confidence

Fair value per share

$17.14

Market price

n/a

PEG ratio

n/a

Enterprise value

$437.5M

Equity value

$324.48M

DCF fair value scenarios

Bear

$11.28

No market comparison
Growth
1%
Discount
11%
Terminal
2%

Base

$17.14

No market comparison
Growth
4%
Discount
10%
Terminal
2.5%

Bull

$26.37

No market comparison
Growth
7%
Discount
9%
Terminal
3%

Base growth: DCF Growth Assumption.

Key valuation metrics

EV/Revenue

n/a

Market price market EV / SEC revenue

Market enterprise value is unavailable

EV/EBITDA

n/a

Market price market EV / SEC EBITDA

Market enterprise value is unavailable

P/E

n/a

Market price market price / SEC EPS

Market cap is unavailable

P/S

n/a

Market price market cap / SEC revenue

Market cap is unavailable

P/B

n/a

Market price market cap / SEC equity

Market cap is unavailable

PEG

n/a

P/E / EPS CAGR

P/e or positive growth is unavailable

Core assumptions

Projection
5 years
FCF growth
4%
Discount rate
10%
Terminal growth
2.5%

SEC fact inputs

DCF base FCF
$30.04M
Trailing SEC FCF
Reported FCF
$30.04M
Net income
$67.16M
EBITDA
$1.26M
Cash
$113.02M
Debt
n/a
Equity
$55M
Shares
18,928,585

Data confidence notes

  • Shares outstanding may be class-specific for multi-class issuers; prefer weighted average share tags when available
  • Dcf base free cash flow: dcf base starts from trailing sec free cash flow
  • Dcf base free cash flow: recent annual free cash flow history is thin
  • Dcf base free cash flow: trailing free cash flow is not positive
  • Dcf confidence is low for this sec-only free cash flow estimate
  • Ticker missing for issuer
  • Debt missing: equity value treats debt as 0
  • Base free cash flow is negative; dcf output is mechanically computed but high risk

Financial Quality Score

Transparent 0-100 scoring model based on profitability, financial health, and growth factors.

58.4/100

Caution Confidence low

Return On Equity

316%

Metric score 100.0/100

Return On Assets

28%

Metric score 100.0/100

Financial Health

Current Ratio
29.1x
Quick Ratio
26.61x

Strengths

Return On Equity and Return On Assets

Watchpoints

Current Ratio and Quick Ratio

Calculation methodology and other links

How we score

This score is transparent and deterministic. We weight profitability, financial health, and growth metrics, then renormalize weights when SEC data is missing.

Metric Weight V1 threshold
ROIC205% to 20%
ROE158% to 25%
ROA102% to 10%
Operating Margin55% to 25%
Current Ratio121.0x to 2.0x
Quick Ratio80.8x to 1.5x
Debt to Equity100.3x to 2.0x (lower is better)
Revenue YoY10-10% to +20%
Net Income YoY10-10% to +20%

How Calculated (standard_v1)

Metrics are computed with a market-consensus convention designed for cross-portal comparability.

  • Operating Income / Revenues using matching TTM or quarter periods; basis shown per metric
  • Current Assets / Current Liabilities (latest instant quarter)
  • (Current Assets - Inventory) / Current Liabilities; fallback: (Cash+Short-Term Investments + Accounts Receivable) / Current Liabilities
  • Total Debt / Stockholders Equity (latest instant quarter; shared unit; freshest series)
  • TTM Net Income / Average Equity (current quarter + same quarter previous year) / 2
  • TTM Net Income / Average Assets (current quarter + same quarter previous year) / 2
  • TTM NOPAT / Average Invested Capital, where NOPAT=Operating Income*(1-tax rate), Invested Capital=Equity+Total Debt-Cash & ST Investments
  • Revenues YoY using available TTM or quarter comparison; basis shown per metric
  • Net Income YoY using available TTM or quarter comparison; basis shown per metric
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .